Background Vaccination has been promoted to control viral transmission in response to the
coronavirus disease 2019 (COVID-19) pandemic. Cases of new-onset or exacerbation of …

To date, over 250 million people have been reportedly infected by COVID‐19 disease,
which has spread across the globe and led to approximately 5.1 million fatalities. To prevent …

Although vaccination is widely accepted as an effective method of preventing and controlling
the COVID‐19 pandemic, many people are concerned about possible cutaneous side …

Because of the increasing emergence of cutaneous reactions from COVID-19 vaccines
worldwide, we investigated the published reports of these complications. We searched the …

The diverse patient population and widespread vaccination in the COVD-19 era make
vaccine-triggered episodes of psoriasis an ideal model of exposome research. This scenario …

COVID-19 vaccination was the main measure to overcome the pandemic. As with other
drugs and vaccines, mild to moderate adverse events have been reported following …

1 Barbieri JS, Rodriguez O, Rosenbach M, Margolis D. Incidence and prevalence of
granuloma Annulare in the United States. JAMA Dermatol 2021; 157: 824–830. https://doi …

The outbreak of coronavirus disease 2019 (COVID-19) represented a new worldwide
challenge, strongly impacting on the global economy, overall health and lifestyle. Since …

Background: Four vaccines have been authorized by the European Medicines Agency
(EMA): viral vector-based vaccines (AstraZeneca; AZD1222 and Johnson & Johnson; Ad26 …

The number of COVID-19 vaccine-rich countries that have started COVID-19 third-dose
booster programs is growing dramatically despite the lack of robust evidence on the …